FPAS
BIIB icon

Focus Partners Advisor Solutions’s Biogen BIIB Stock Holding History

Focus Partners Advisor Solutions’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.65M Buy
9,011
+1,506
+20% +$277K 0.02% 403
2025
Q4 		$1.32M Buy
7,505
+118
+2% +$19.3K 0.02% 418
2025
Q3 		$1.13M Buy
7,387
+1,076
+17% +$145K 0.01% 482
2025
Q2 		$793K Buy
6,311
+1,010
+19% +$126K 0.01% 511
2025
Q1 		$725K Buy
+5,301
New +$758K 0.01% 469
2024
Q4 		– Sell
-1,655
Closed -$321K – 780
2024
Q3 		$321K Buy
1,655
+539
+48% +$113K 0.01% 550
2024
Q2 		$259K Buy
1,116
+152
+16% +$33K 0.01% 525
2024
Q1 		$208K Buy
+964
New +$226K 0.01% 574
2023
Q1 		– Sell
-757
Closed -$210K – 360
2022
Q4 		$210K Sell
757
-919
-55% -$260K 0.02% 318
2022
Q3 		$448K Buy
+1,676
New +$356K 0.03% 240

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Focus Partners Advisor Solutions's BIIB Position: Q1 2026 in Review

Focus Partners Advisor Solutions increased its Biogen (BIIB) stake by 20% in Q1 2026, buying an estimated $277K and bringing the position to 9,011 shares worth $1.65M. The position accounts for 0.02% of the portfolio, ranked #403.

Focus Partners Advisor Solutions first reported a position in BIIB in Q3 2022 and has held it in 10 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Focus Partners Advisor Solutions held 9,011 shares of Biogen worth $1.65M as of Q1 2026.
  • Focus Partners Advisor Solutions bought 1,506 Biogen shares in Q1 2026, an estimated $277K.
  • Biogen made up 0.02% of Focus Partners Advisor Solutions's portfolio in Q1 2026, its #403 holding.
  • Focus Partners Advisor Solutions first reported a position in Biogen in Q3 2022 and has held it in 10 quarters since.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q1 2026, filed 13 May 2026.